Z. Sapi et al., CONTRIBUTION OF P53 GENE ALTERATIONS TO DEVELOPMENT OF METASTATIC FORMS OF FOLLICULAR THYROID-CARCINOMA, Diagnostic molecular pathology, 4(4), 1995, pp. 256-260
Alterations of p53 suppressor gene as a possible indicator of the meta
static potential of thyroid carcinomas were evaluated in a cohort of 4
5 thyroid carcinomas. Well-differentiated papillary and follicular car
cinomas were evaluated; the poorly differentiated and the undifferenti
ated forms were excluded from the studies. Tumors were divided into tw
o groups: those giving no metastasis for > 10 years and those developi
ng metastasis within 5 years. Gene alterations were tested by immunocy
tochemical detection of p53 gene expression and by determining loss of
heterozygosity (LOH), Considering the two methods together, p53 damag
es were observed in two out of 11 papillary carcinomas without metasta
sis (18.1%), one out of nine papillary carcinomas with metastasis (11.
1%), two out of 14 follicular carcinomas without metastasis (14.2%), a
nd five out of II follicular carcinomas with metastasis (45.4%). Stati
stical chi(2) test showed significantly (p = 0.05) only between follic
ular carcinomas with and without metastasis thus p53 damage may have a
n impact for metastatic potential of follicular thyroid carcinomas.